Castle Total Assets vs Current Deferred Revenue Analysis
CSTL Stock | USD 24.92 0.02 0.08% |
Castle Biosciences financial indicator trend analysis is way more than just evaluating Castle Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Castle Biosciences is a good investment. Please check the relationship between Castle Biosciences Total Assets and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.
Total Assets vs Current Deferred Revenue
Total Assets vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Castle Biosciences Total Assets account and Current Deferred Revenue. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Castle Biosciences' Total Assets and Current Deferred Revenue is 0.81. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Castle Biosciences, assuming nothing else is changed. The correlation between historical values of Castle Biosciences' Total Assets and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Castle Biosciences are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Total Assets i.e., Castle Biosciences' Total Assets and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.81 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Total Assets
Total assets refers to the total amount of Castle Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Castle Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from Castle Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Castle Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.Tax Provision is expected to rise to about 125 K this year, although the value of Selling General Administrative will most likely fall to about 50.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1K | 17K | 11K | 10.5K | Depreciation And Amortization | 3.5M | 14.5M | 12.3M | 12.9M |
Castle Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Castle Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Castle Biosciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 119.7M | 439.3M | 462.6M | 447.3M | 477.8M | 311.0M | |
Short Long Term Debt Total | 24.5M | 25.1M | 8.1M | 13.3M | 15.3M | 14.0M | |
Other Current Liab | 7.6M | 12.2M | 21.2M | 29.6M | 36.3M | 38.1M | |
Total Current Liabilities | 15.3M | 20.9M | 24.9M | 36.1M | 47.7M | 24.6M | |
Total Stockholder Equity | 85.1M | 415.7M | 411.7M | 399.2M | 391.3M | 263.8M | |
Other Liab | 55K | 2.8M | 19.0M | 428K | 492.2K | 467.6K | |
Net Tangible Assets | 85.1M | 415.7M | 322.8M | 272.8M | 313.7M | 181.4M | |
Property Plant And Equipment Net | 2.1M | 7.1M | 16.9M | 26.5M | 37.7M | 39.6M | |
Net Debt | (73.7M) | (409.9M) | (321.6M) | (109.6M) | (83.5M) | (87.7M) | |
Retained Earnings | (52.2M) | (62.5M) | (93.8M) | (160.9M) | (218.4M) | (207.5M) | |
Accounts Payable | 1.9M | 2.1M | 2.5M | 4.7M | 10.3M | 10.8M | |
Cash | 98.8M | 409.9M | 329.6M | 122.9M | 98.8M | 167.5M | |
Non Current Assets Total | 3.1M | 9.7M | 108.8M | 155.0M | 182.2M | 191.3M | |
Non Currrent Assets Other | 135K | 1.5M | 3.0M | (25.6M) | 1.4M | 1.5M | |
Other Assets | 1.0M | 2.6M | 3.0M | 2.2M | 2.5M | 2.4M | |
Cash And Short Term Investments | 98.8M | 409.9M | 329.6M | 258.6M | 243.1M | 211.5M | |
Net Receivables | 14.6M | 12.8M | 17.3M | 23.5M | 38.3M | 19.4M | |
Common Stock Shares Outstanding | 8.7M | 18.9M | 25.1M | 26.1M | 26.8M | 19.8M | |
Liabilities And Stockholders Equity | 119.7M | 439.3M | 462.6M | 447.3M | 477.8M | 311.0M | |
Non Current Liabilities Total | 19.3M | 2.8M | 25.9M | 12.1M | 38.9M | 22.6M | |
Inventory | 1.2M | 2.2M | 2.0M | 4.0M | 7.9M | 8.3M | |
Other Current Assets | 2.0M | 4.8M | 4.8M | 6.2M | 6.3M | 4.0M | |
Other Stockholder Equity | 137.3M | 478.2M | 505.5M | 560.4M | 609.5M | 360.5M | |
Total Liab | 34.6M | 23.6M | 50.8M | 48.2M | 86.5M | 47.2M | |
Net Invested Capital | 110.2M | 415.7M | 411.7M | 399.2M | 391.3M | 261.5M | |
Property Plant And Equipment Gross | 2.1M | 7.1M | 16.9M | 26.5M | 45.9M | 48.1M | |
Total Current Assets | 116.7M | 429.6M | 353.7M | 292.3M | 295.6M | 237.7M | |
Accumulated Other Comprehensive Income | (909.4K) | (119.7M) | 0.0 | (381K) | 136K | 142.8K | |
Net Working Capital | 101.4M | 408.7M | 328.9M | 256.2M | 248.0M | 213.1M | |
Common Stock | 1.9K | 17K | 25K | 27K | 31.1K | 19.6K | |
Property Plant Equipment | 2.1M | 7.1M | 16.9M | 26.5M | 30.5M | 32.0M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Castle Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Castle Stock analysis
When running Castle Biosciences' price analysis, check to measure Castle Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Castle Biosciences is operating at the current time. Most of Castle Biosciences' value examination focuses on studying past and present price action to predict the probability of Castle Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Castle Biosciences' price. Additionally, you may evaluate how the addition of Castle Biosciences to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Castle Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share (1.13) | Revenue Per Share 9.279 | Quarterly Revenue Growth 0.736 | Return On Assets (0.06) |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.